SCNI

Conviction 0Scan · Mon, Aug 10, 2026

SCNI$0.2516+2.57%

ResistanceSupportVol 14

Vol MA14 522.45K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Scinai Immunotherapeutics Ltd.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.scinai.com ↗

Price0.2516

Change+2.57%

Gap+2.57%

Rel volume0.00×

Avg volume855.97K

Avg $ vol219.14K

SMA 200.2542

SMA 500.2980

SMA 2000.6921

Price vs 50-15.56%

Price vs 200-63.65%

MA stackbearish

50/200 cross—

Supertrenddown · 0.3243

RSI (14)43

MACD hist0.00

MACD cross—

Stoch %K / %D22 / 22

ADX (14)19

+DI / −DI24 / 19

RSI divergence—

MACD divergence—

ATR %+13.43%

ADR %12.83%

52w high1.82

52w low0.2300

From 52w high-86.18%

Above 52w low+9.39%

New 52w highNo

SqueezeOn · 18d

Bollinger width18.24%

%B0.44

Donchian pos22.32%

Donchian high0.3800

Donchian low0.2147

AVWAP (52w high)0.7813

vs AVWAP high-67.80%

AVWAP (52w low)0.2772

vs AVWAP low-9.23%

OBV trendUp

Chaikin MF (20)-0.48

Today vs 20d0.00×

Avg vol (14d)522.45K

Avg vol (20d)855.97K

Avg $ vol (20d)219.14K

Market cap—

RS 3m (vs SPY)-60.56%

RS 6m (vs SPY)-85.21%

RS line new highNo

Trend template0/8

Technical rank17.7

1 week-7.84%

1 month+0.36%

3 months-55.69%

6 months-69.75%

1 year-83.66%

YTD-65.51%

P/E-619.45

P/B-746.43

P/S—

P/FCF-443.19

EPS-0.0100

Div yield—

ROE120.50%

ROA-24.88%

Debt/Eq-0.08

Current4.28

EV/EBITDA-340.97

Gross margin—

Net margin—

Rev growth—

EPS growth29.37%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value3.58B

Revenue—

Net income-3.52M

Gross profit—

Free cash flow-8.1M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out3.96M

Employees45

ListedTue, May 12, 2015

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank17.7 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.3335

Support0.2150

Days since event—

Candle confirm—

News sentiment—

Financials as of Fri, Mar 31, 2023 · quarterly.

Congress activity

Disclosed STOCK Act trades in SCNI

All disclosures →

No recent disclosed trades by Congress in SCNI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SCNI · 2 buys

Insider	Side	Shares	Value	Traded	Filed
Reichman Amir Chief Executive Officer · Ordinary Shares · 2026-06-16	Grant	400M	—	2026-06-16	2026-06-18
GERMAIN MARK Director · Ordinary Shares · 2026-06-16	Grant	120M	—	2026-06-16	2026-06-18

SEC filings

EDGAR filings in SCNI · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.